GlassScriptPhysician profile
David Alexander Jerkins
NPI 1992060172
$4,187.25
in general payments reported to CMS, 2019-2025
16 companies · $1,946 in 2025
The $1,946 reported for 2025 was more than what 84% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $31.79 · 2021: $1,253 · 2022: $274 · 2023: $40.63 · 2024: $419 · 2025: $1,946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,206 · Travel and Lodging: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,206.09 |
| Travel and Lodging | $1,199.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,038.47 | 2024-2025 | |
| Stryker Corporation | $1,112.51 | 2021 | |
| Allergan, INC. | $361.43 | 2019-2022 | |
| Mentor Worldwide LLC | $145.57 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Convatec INC. | $117.63 | 2024-2025 | |
| Sientra, INC. | $99.02 | 2019-2022 | |
| Kerecis Limited | $79.61 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $57.95 | 2019 | |
| Integra Lifesciences Corporation | $37.02 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Pacira Pharmaceuticals Incorporated | $31.21 | 2019-2024 | Exparel |
| Merck Sharp & Dohme LLC | $27.52 | 2025 | Bridion |
| Polynovo North America LLC | $23.49 | 2025 | Novosorb Btm |
| Biocompatibles, INC. | $21.69 | 2019 | |
| Solventum Corporation | $15.00 | 2024 | Activ.A.C., V.A.C. Granufoam, V.A.C. Dermatac |
| Depuy Synthes Sales INC. | $11.52 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $7.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jerkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.